Blog

Artificial Intelligence for drug discovery at Mind the Byte

Artificial intelligence (AI) has become a hot topic in the biopharmaceutical environment and nearly every pharma company in the world has embraced it hoping that it will play a major role in speeding up drug discovery, by reducing R&D costs and avoiding...

SmartDock: Artificial Intelligence for Drug Discovery

We are happy to introduce SmartDock, a prototype system to discriminate binders and non-binders from docking results based on Artificial Intelligence. The pharmacologic impact of drugs depends on their ability to engage and occupy physiologically relevant...

VET in bioinformatics, a good way to attract young talent

Vocational Education and Training (commonly known as VET) in bioinformatics is sure to be a way for many young people to enter the job market and a good gateway to companies in the healthcare and life sciences sector looking to add junior technicians to...

Computational drug discovery for safer drugs

Some weeks ago six people were hospitalized (one dead) after receiving a trial treatment of a new drug (BIA-10-2474), they were participating in a clinical trial. Some researchers have questioned the design of this fatal clinical trial. Ignoring the fact...

Intrinsically Disordered Proteins (IDPs) and Drug Discovery

Intrinsically Disordered Proteins (IDPs) are an emerging family of proteins whose which characteristic feature is that they don't present a folded structure, and thus challenge the sequence-structure-function paradigm. This lack of stable structure, over...